Results 301 to 310 of about 200,281 (336)

Diagnostics of Autoimmune Hepatitis Enabled by Non‐Invasive Clinical Proteomics

open access: yesAlimentary Pharmacology &Therapeutics, Volume 62, Issue 9, Page 901-919, November 2025.
Mass‐spectrometry‐based proteomic analyses of paired liver‐plasma samples from patients with AIH enabled discovery of numerous proteins showing high diagnostic accuracy. Proteomics may constitute a novel non‐invasive diagnostic tool for AIH if validated in larger, age‐ and sex‐matched cohorts.
Anne‐Sofie Houlberg Jensen   +20 more
wiley   +1 more source

Light-Chain Cardiac Amyloidosis: Cardiac Magnetic Resonance for Assessing Response to Chemotherapy

open access: gold
Yubo Guo   +13 more
openalex   +2 more sources

Molecular Expression Differences in Specific Blood Mononuclear Cell-Types Identify Patients With AL Amyloidosis. [PDF]

open access: yesJ Cell Mol Med
Kaplan D   +11 more
europepmc   +1 more source

Fourier ptychography microscopy for digital pathology

open access: yesJournal of Microscopy, Volume 300, Issue 2, Page 260-285, November 2025.
Abstract Fourier ptychography microscopy (FPM) has made significant progress since its invention in 2013, thanks to its adaptable nature, high resolution, and vast field‐of‐view capabilities. FPM is used in various medical applications across multiple optical wavelengths, from automated digital pathology to radiology and ultraviolet label‐free imaging.
Fraser Eadie   +4 more
wiley   +1 more source

Apolipoprotein A-IV fibrils: structural diagnosis of mixed cardiac amyloidosis. [PDF]

open access: yesNat Commun
Aibara S   +9 more
europepmc   +1 more source

An updated AL-Base reveals ranked enrichment of immunoglobulin light chain variable genes in AL amyloidosis

open access: green
Gareth J. Morgan   +8 more
openalex   +1 more source

Amyloid‐β Seeds in Alzheimer's Disease: Research Challenges and Implications

open access: yesJournal of Neurochemistry, Volume 169, Issue 11, November 2025.
The amyloid cascade hypothesis places amyloid‐β (Aβ) at the center of Alzheimer's disease (AD) pathogenesis. Evidence suggests that AD progresses in two phases: an early phase driven by Aβ aggregation and a later phase that progresses at least partly independently of Aβ.
Natalie Beschorner   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy